Arcturus Therapeutics Holdings, Inc. (ARCT)
13.76
+0.89
(+6.92%)
USD |
NASDAQ |
Oct 09, 12:56
Arcturus Therapeutics Holdings EPS Diluted (Quarterly) : -0.8368 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8368 |
| March 31, 2026 | -0.9487 |
| December 31, 2025 | -1.034 |
| September 30, 2025 | -0.4946 |
| June 30, 2025 | -0.3384 |
| March 31, 2025 | -0.5193 |
| December 31, 2024 | -1.111 |
| September 30, 2024 | -0.2551 |
| June 30, 2024 | -0.6384 |
| March 31, 2024 | -0.9977 |
| December 31, 2023 | -0.3219 |
| September 30, 2023 | -0.6105 |
| June 30, 2023 | -1.978 |
| March 31, 2023 | 1.870 |
| December 31, 2022 | 4.333 |
| September 30, 2022 | -1.332 |
| June 30, 2022 | -0.816 |
| March 31, 2022 | -1.94 |
| December 31, 2021 | -1.467 |
| September 30, 2021 | -2.054 |
| June 30, 2021 | -2.074 |
| March 31, 2021 | -2.147 |
| December 31, 2020 | -1.250 |
| September 30, 2020 | -0.9157 |
| June 30, 2020 | -0.5461 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.6733 |
| December 31, 2019 | -0.7576 |
| September 30, 2019 | -0.5631 |
| June 30, 2019 | -0.0658 |
| March 31, 2019 | -0.6819 |
| December 31, 2018 | -0.0943 |
| September 30, 2018 | -0.4214 |
| June 30, 2018 | -0.9894 |
| March 31, 2018 | -0.6553 |
| December 31, 2017 | -0.11 |
| September 30, 2017 | -0.63 |
| June 30, 2017 | -0.91 |
| March 31, 2017 | -0.91 |
| December 31, 2016 | -1.54 |
| September 30, 2016 | -1.96 |
| June 30, 2016 | -1.47 |
| March 31, 2016 | -1.292 |
| December 31, 2015 | -1.40 |
| September 30, 2015 | -1.40 |
| June 30, 2015 | -1.68 |
| March 31, 2015 | -1.798 |
| December 31, 2014 | -3.50 |
| September 30, 2014 | -5.39 |
| June 30, 2014 | -3.99 |
| March 31, 2014 | -3.99 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Exelixis, Inc. | 0.8166 |
| Ionis Pharmaceuticals, Inc. | -0.6931 |
| United Therapeutics Corp. | 7.271 |
| PTC Therapeutics, Inc. | 0.9178 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.78M |
| Revenue (Quarterly) | 0.88M |
| Total Expenses (Quarterly) | 24.66M |
| Enterprise Value | 197.25M |
| Gross Profit Margin (Quarterly) | 31.82% |
| Profit Margin (Quarterly) | -2.70K% |
| Earnings Yield | -24.09% |
| Normalized Earnings Yield | -22.72 |